Clinical Trials Directory

Trials / Unknown

UnknownNCT01097811

Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy

Erythromycin Versus Neomycin Treatment for Overt Hepatic Encephalopathy: a Double-blind, Randomised, Controlled Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
UPECLIN HC FM Botucatu Unesp · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Comparison between the efficacy of two different antibiotics in patients with overt hepatic encephalopathy. The study is randomized, controlled and double-blinded.

Conditions

Interventions

TypeNameDescription
DRUGErythromycin250 mg orally q.i.d.
DRUGNeomycin1 g orally q.i.d.

Timeline

Start date
2008-06-01
Primary completion
2010-06-01
Completion
2010-12-01
First posted
2010-04-02
Last updated
2010-04-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01097811. Inclusion in this directory is not an endorsement.

Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy (NCT01097811) · Clinical Trials Directory